PTPN11
PTPN11 (Protein Tyrosine Phosphatase, Non-Receptor Type 11) is a gene that encodes the protein SH2 domain-containing protein tyrosine phosphatase-2 (SHP2). This protein is a key component in several cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation.
Function[edit]
The PTPN11 gene provides instructions for making the SHP2 protein, which is found in various cell types throughout the body. The SHP2 protein is involved in transmitting chemical signals from outside the cell to the cell's nucleus. These signals instruct the cell to grow and divide or to mature and take on specialized functions (differentiate). The SHP2 protein is particularly important for the normal development and function of several body systems, including the cardiovascular system, the nervous system, and the endocrine system.
Clinical significance[edit]
Mutations in the PTPN11 gene are associated with Noonan syndrome and Leopard syndrome, both of which are autosomal dominant conditions that cause congenital heart defects, short stature, learning problems, and facial features that are distinctive to each condition. Mutations in this gene are also associated with juvenile myelomonocytic leukemia, a rare form of cancer that typically occurs in early childhood.
Research[edit]
Research into the PTPN11 gene and its associated protein, SHP2, is ongoing. Understanding the normal function of this gene and how mutations affect its function can lead to better treatments for the conditions associated with it. Current research is focused on understanding the role of the PTPN11 gene in normal development and disease, and developing targeted therapies for conditions caused by mutations in this gene.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
